Saturday, July 11, 2026

pharma · Neurological Autoimmune Diseases

Juventas Cell Therapy

Juventas Cell Therapy clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Juventas Cell Therapy projects

1 ClinicalTrials.gov programs sponsored by Juventas Cell Therapy.

Juventas Cell Therapy has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CNCT19 cell injection

    Juventas Cell Therapy

    Neurological Autoimmune Diseases

    phase 1 mab active

    1 trial

Frequently asked questions

How many clinical projects does Juventas Cell Therapy have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.